Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Lonial

Showing results (161-170 of 440) with videos related to

Pageof 44
Sort By:
Cancer|April 21, 2012
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemiaMartha Arellano, Suchita Pakkala, Amelia Langston, et al.
Cancer Medicine|April 28, 2016
Lack of health maintenance examinations and risk in myeloma patientsJoseph D Tariman, Charise Gleason, Beth Faiman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2003
Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effectsCynthia R Giver, Richard O Montes, Stephen Mittelstaedt, et al.
Leukemia|July 28, 2016
HLA polymorphism and risk of multiple myelomaMeral Beksac, Loren Gragert, Stephanie Fingerson, et al.
Blood Cancer Journal|December 15, 2020
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myelomaYanyan Gu, Benjamin G Barwick, Mala Shanmugam, et al.
Cancer|September 6, 2013
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trialsAjay K Nooka, Jonathan L Kaufman, Madhusmita Behera, et al.
Blood|January 25, 2002
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantationAmelia A Langston, Istvan Redei, Angela M Caliendo, et al.
Plos One|February 27, 2019
Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft modelsTaofeek K Owonikoko, Guojing Zhang, Shenila B Lallani, et al.
Expert Review of Hematology|May 14, 2021
Selinexor for the treatment of patients with previously treated multiple myelomaClifton C Mo, Sundar Jagannath, Ajai Chari, et al.
JCO Oncology Practice|May 29, 2020
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and OutcomesPelin Cinar, John Cox, Arif Kamal, et al.
Pageof 44

Showing results (161-170 of 440) with videos related to

Sort By:
Pageof 44
Cancer|April 21, 2012
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemiaMartha Arellano, Suchita Pakkala, Amelia Langston, et al.
Cancer Medicine|April 28, 2016
Lack of health maintenance examinations and risk in myeloma patientsJoseph D Tariman, Charise Gleason, Beth Faiman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2003
Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effectsCynthia R Giver, Richard O Montes, Stephen Mittelstaedt, et al.
Leukemia|July 28, 2016
HLA polymorphism and risk of multiple myelomaMeral Beksac, Loren Gragert, Stephanie Fingerson, et al.
Blood Cancer Journal|December 15, 2020
Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myelomaYanyan Gu, Benjamin G Barwick, Mala Shanmugam, et al.
Cancer|September 6, 2013
Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trialsAjay K Nooka, Jonathan L Kaufman, Madhusmita Behera, et al.
Blood|January 25, 2002
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantationAmelia A Langston, Istvan Redei, Angela M Caliendo, et al.
Plos One|February 27, 2019
Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft modelsTaofeek K Owonikoko, Guojing Zhang, Shenila B Lallani, et al.
Expert Review of Hematology|May 14, 2021
Selinexor for the treatment of patients with previously treated multiple myelomaClifton C Mo, Sundar Jagannath, Ajai Chari, et al.
JCO Oncology Practice|May 29, 2020
Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and OutcomesPelin Cinar, John Cox, Arif Kamal, et al.
Pageof 44